Rezo - About the company
Rezo is a series A company based in San Francisco (United States), founded in 2021 by Sourav Bandyopadhyay, George Scangos, Kevan Shokat, Norbert Bischofberger and Natalia Jura. It operates as an AI-powered genomics platform for targeted disease therapeutics. Rezo has raised $78M in funding from investors like Andreessen Horowitz, SR One and Norwest. The company has 549 active competitors, including 200 funded and 127 that have exited. Its top competitors include companies like Alnylam, Forge Biologics and Strand Therapeutics.
Company Details
AI-powered genomics platform for targeted disease therapeutics. The company has a Sequence to Systems to Drugs (SSD) platform that integrates proteomics, genetics, structural biology, chemistry, and bioinformatics to create maps of molecular disease networks, initially focused on solid tumor oncology guided by mutation and allele-specific biomarkers.
- Website
- rezotx.com
- Email ID
- *****@rezotx.com
Key Metrics
Founded Year
2021
Location
San Francisco, United States
Stage
Series A
Total Funding
$78M in 1 round
Latest Funding Round
Investors
Ranked
108th among 549 active competitors
Employee Count
46 as on Sep 30, 2026
Legal entities associated with Rezo
Rezo is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
REZO CIN: 40003500473 , Latvia, Deadpooled | Jul 04, 2000 | €0 - €1M (As on Dec 31, 2017) | 1 (As on Dec 31, 2022) | - |
Rezo Therapeutics, Inc. CIN: 6424956 , United States, Active | Dec 31, 2020 | - | - | - |
Sign up to download Rezo's company profile
Rezo's funding and investors
Rezo has raised a total funding of $78M over 1 round. Its latest funding round was a Series A round on Jul 21, 2022 for $*****. 6 investors participated in its latest round. Rezo has 7 institutional investors.
Here is the list of recent funding rounds of Rezo:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2022 | 7681299 | Series A | 8654326 | 7767187 | 7580035 | 9750779 |
Access funding benchmarks and valuations. Sign up today!View details of Rezo's funding rounds and investors
Rezo's founders and board of directors
Founder? Claim ProfileThe founders of Rezo are Sourav Bandyopadhyay, George Scangos, Kevan Shokat, Norbert Bischofberger and Natalia Jura.
Here are the details of Rezo's key team members:
- Sourav Bandyopadhyay: Co-Founder of Rezo. They serve on the board of 1 company.
- George Scangos: Co-Founder of Rezo. They serve on the board of 1 company.Contact Info: 1 email address
- Kevan Shokat: Co-Founder of Rezo.
- Norbert Bischofberger: Co-Founder of Rezo.
- Natalia Jura: Co-Founder of Rezo.
Rezo's Board of Directors
Rezo's board has 7 active members. Norbert Bischofberger, Sourav Bandyopadhyay, George Scangos, Simeon J George, Vineeta Agarwala, Nadir Mahmood and Nevan Krogan are independent board members.Here is the list of Rezo's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 3y 10m | |
qcmhqsb | Independent board member | - | Current | 4y 2m |
cglbjr{ | Independent board member | - | Current | 5y 8m |
srbhjwj | Independent board member | - | Current | 4y 5m |
{vaj{jz | Independent board member | - | Current | 9y 1m |
pshnus{ | Independent board member | - | Current | 6y 7m |
ikfxajp | Independent board member | - | Current | 5y 3m |
View details of Rezo's Founder profiles and Board Members
Rezo's employee count trend
Rezo has 46 employees as of Sep 26. Here is Rezo's employee count trend over the years:
Uncover Rezo's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Rezo's Competitors and alternates
Top competitors of Rezo include Alnylam, Forge Biologics and Strand Therapeutics. Here is the list of Top 10 competitors of Rezo, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | 80/100 | |
2nd |  Forge Biologics 2020, Columbus (United States), Acquired | Developer of gene therapeutic solutions for treating multiple diseases | $330M | 72/100 | |
3rd |  Strand Therapeutics 2017, Cambridge (United States), Series B | Provider of platform to deliver mRNA therapeutics for multi functional treatments | $256M | 71/100 | |
4th | Spark Therapeutics 2013, Philadelphia (United States), Acquired | Developer of gene therapy for rare diseases | $82.8M | 69/100 | |
5th | Ionis 1989, United States, Public | Developer of RNA-targeted medicines for various diseases | - | 69/100 | |
6th | Stoke Therapeutics 2014, Bedford (United States), Public | Developer of antisense oligonucleotide drugs for treating inherited diseases by targeting RNA splicing | $131M | 68/100 | |
7th | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of genome editing therapeutics using CRISPR and Cas9 technology | $85M | 68/100 | |
8th | Sirnaomics 2007, Gaithersburg (United States), Public | Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease | $267M | 67/100 | |
9th |  Dyne Therapeutics 2017, Cambridge (United States), Public | Developer of nucleic acid therapies for rare diseases | $166M | 67/100 | |
10th | Aspen Neuroscience 2018, San Diego (United States), Series C | Provider of genomic-based personalised pluripotent stem cell therapy | $339M | 67/100 | |
108th |  Rezo 2021, San Francisco (United States), Series A | AI-powered genomics platform for targeted disease therapeutics | $78M | 52/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Rezo's competitors? Click here to see the top ones
Rezo's Investments and acquisitions
Rezo has made no investments or acquisitions yet.
Reports related to Rezo
Here is the latest report on Rezo's sector:
News related to Rezo
•
Rezo Therapeutics Appoints Cristiana Guiducci, Ph.D., as Chief Scientific OfficerBusiness Wire•Jul 18, 2024•Rezo
•
•
Rezo Therapeutics Launches With $78M in Series A FundingGenomeWeb•Nov 18, 2022•Rezo, SR One, Andreessen Horowitz, Norwest Venture Partners and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Rezo
Explore our recently published companies
- Hello Syndic - Paris based, 2017 founded, Unfunded company
- Giddaa - Middletown based, 2023 founded, Unfunded company
- Assistive - San Francisco based, 2023 founded, Unfunded company
- Himalayanorganicindia - India based, Unfunded company
- Sierra Technology and Business - Saudi Arabia based, 2023 founded, Unfunded company
- Energy3K - Unfunded company
